Registration - Consultant Lobbyist
Innovative Medicines Canada / Bradley Lavigne, Consultant Lobbyist
Registration Information
Lobbyist name: Bradley Lavigne, Consultant Lobbyist
Initial registration start date: 2021-11-04
Registration status: Inactive
Registration number: 1688-4393
Associated Lobbying Activity Reports
Total number of Lobbying Activity Reports: 1
Lobbying Activity Reports - last 6 months: 0
Version 4 of 4 (2023-05-02 to 2023-05-31)
Version 4 of 4 (2023-05-02 to 2023-05-31)
Lobbying Information
Details Regarding the Identified Subject Matter |
|||||||
| Will the consultant lobbyist be arranging meetings between a public office holder and the client for the purpose of attempting to influence any of the matters listed: | Yes | ||||||
|
|||||||
BC Ministries/Provincial Entities
- Health
- Jobs, Economic Development and Innovation
- Member(s) of the BC Legislative Assembly
- Office of the Premier
Contingency Information
- Payment to the consultant lobbyist by the client, in whole or in part, is not contingent on the outcome of this lobbying activity.
- Payment to the consultant lobbyist by the client, in whole or in part, is not contingent on the success in arranging a meeting with public office holders on behalf of the client.
Client Details
Client Contact Information
Innovative Medicines Canada
Address:
120-55 Metcalfe Street
Ottawa, ON K1P 6L5
Canada
Telephone number:
613-236-0455
Website:
www.innovativemedicines.ca
Description of Business Activities
Innovative Medicines Canada (IMC) represents Canada's innovative pharmaceutical industry. The association helps its members discover, develop, and deliver innovative medicines and vaccines. IMC's membership consists of 40 companies, from established organizations to fledgling startups, all of which are revolutionizing healthcare through the discovery and development of new medicines and vaccines. Guided by a strict Code of Ethical Practices, IMC works with governments, insurance companies, healthcare professionals and stakeholders to advance the field and enhance the well-being of Canadians. IMC is committed to being valued partners in Canada's healthcare system and aims to achieve these goals by forming effective alliances and supporting policies, improving Canada's regulatory environment, widening access to innovative medicines and protecting intellectual property.
Contributors to the Lobbying Activity
No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of the organization that has a direct interest in the outcome of the lobbying activity.
Government Funding in the Last 12 Months
No government funding was requested or received within the preceding 12 months.Coalition Members Information
Innovative Medicines Canada is not a coalition member.
Affiliates with a Direct Interest in the Outcome
Innovative Medicines Canada does not have any affiliates that could have a direct interest in the outcome of the lobbying activities
Other Persons or Organizations with Direct Interests
The activities of Innovative Medicines Canada are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking.
Lobbyist Details
Bradley Lavigne |
95 St. Clair Avenue West
Suite 1606
Toronto, ON M4V 1N6
Canada
Relevant Codes of Conduct
The consultant lobbyist does not have in place an undertaking to comply with any relevant codes of conduct.
Political, Sponsorship and Recall Contributions
| Consultant has lobbied, or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this client, on or after 2020-09-21: | Yes | |||||||||||||||
|
||||||||||||||||
Gifts or Benefits Provided to Public Officer Holders
No gifts or benefits were provided to public office holdersIndividuals Hired or Subcontracted to Lobbying on behalf of the Client
No recordsConsultant Lobbyist Firm and Address
Firm: Counsel Public Affairs Inc.
95 St. Clair Avenue West
Suite 1606
Toronto, ON M4V 1N6
Canada
- Date Modified: